Drug:
Reaction: NASOPHARYNGITIS
20260101 - 20261231
No. 701 - 800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 701 | 26446344 |
US |
41 | 2 |
Illness, Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 702 | 26446360 |
US |
44 | 2 |
Nasopharyngitis, |
||||
AGALSIDASE BETA, |
||||
| 703 | 26446398 |
US |
38 | 2 |
Acne, Nasopharyngitis, Oral herpes, Condition aggravated, |
||||
DUPILUMAB, |
||||
| 704 | 26446581 |
US |
76 | 1 |
Carpal tunnel decompression, Nasopharyngitis, Sinus congestion, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 705 | 26446618 |
US |
1 | |
Prostatic artery embolisation, Nasopharyngitis, |
||||
RISANKIZUMAB-RZAA, |
||||
| 706 | 26446679 |
US |
63 | 2 |
Rash papular, Influenza, Nasopharyngitis, Cough, Furuncle, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 707 | 26446795 |
US |
63 | 2 |
Rhinorrhoea, Chills, Oropharyngeal pain, Nasopharyngitis, Nasal congestion, Sinusitis, |
||||
DUPILUMAB, DUPILUMAB, OFATUMUMAB, |
||||
| 708 | 26446850 |
US |
32 | 1 |
Nasopharyngitis, Oropharyngeal discomfort, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 709 | 26447027 |
US |
1 | |
Nasopharyngitis, |
||||
SPARSENTAN, |
||||
| 710 | 26447181 |
US |
50 | 2 |
Foot operation, Medical device implantation, Arthritis, Respiratory disorder, Nasopharyngitis, Sinus disorder, |
||||
UPADACITINIB, |
||||
| 711 | 26447240 |
US |
82 | 1 |
Pneumonia, Pyrexia, Cough, Nasopharyngitis, |
||||
DUPILUMAB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 712 | 26447254 |
US |
1 | |
Weight increased, Vertigo, Illness, Nasopharyngitis, |
||||
ABIRATERONE ACETATE, ABIRATERONE, DONEPEZIL HYDROCHLORIDE, ENSIFENTRINE, ENSIFENTRINE, ALBUTEROL SULFATE, BUDESONIDE, CELECOXIB, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, PREDNISONE, GUAIFENESIN, REVEFENACIN, FUROSEMIDE, |
||||
| 713 | 26447279 |
US |
62 | 2 |
Oropharyngeal pain, Nausea, Ear pain, Pain in jaw, Nasopharyngitis, Fatigue, |
||||
SPARSENTAN, |
||||
| 714 | 26447312 |
US |
66 | 1 |
Rhinorrhoea, Cough, Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 715 | 26447351 |
US |
1 | |
Nasopharyngitis, Cough, |
||||
ABIRATERONE ACETATE, ABIRATERONE, RELUGOLIX, RELUGOLIX, POLYETHYLENE GLYCOL 3350, PREDNISONE, HYDROXYCHLOROQUINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), TAMSULOSIN HYDROCHLORIDE, CALCIUM, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, NAPROXEN, NAPROXEN SODIUM, |
||||
| 716 | 26447370 |
US |
39 | 2 |
Dizziness postural, Blood pressure decreased, Nasopharyngitis, Pyrexia, |
||||
SPARSENTAN, |
||||
| 717 | 26447391 |
US |
2 | |
Nasopharyngitis, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 718 | 26447582 |
US |
62 | 2 |
Feeling abnormal, Product dose omission issue, COVID-19, Asthenia, Fatigue, Palpitations, Hypertension, Dyspnoea, Amnesia, Nasopharyngitis, Dizziness, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 719 | 26447638 |
US |
1 | |
Productive cough, Nasopharyngitis, |
||||
DUPILUMAB, MENTHOL, METHYL SALICYLATE, GUAIFENESIN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CALCIUM CARBONATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 720 | 26447675 |
US |
2 | |
Nasopharyngitis, Back pain, |
||||
SPARSENTAN, |
||||
| 721 | 26447721 |
US |
1 | |
Nasopharyngitis, Product use in unapproved indication, |
||||
DUPILUMAB, FUROSEMIDE, PANTOPRAZOLE, SPIRONOLACTONE, RIVAROXABAN, |
||||
| 722 | 26448154 |
US |
50 | 1 |
Nasopharyngitis, |
||||
EVOLOCUMAB, |
||||
| 723 | 26448302 |
JP |
29 | 2 |
Melaena, Lymphocyte count decreased, Nasopharyngitis, |
||||
OZANIMOD HYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 724 | 26441694 |
US |
2 | |
Dysphonia, Illness, Nasopharyngitis, Ill-defined disorder, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 725 | 26441916 |
US |
34 | 2 |
Nasopharyngitis, Influenza, Nausea, Hot flush, Vomiting, Weight decreased, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, KETAMINE HYDROCHLORIDE, HYDROCORTISONE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, CLONIDINE, KETOPROFEN, OXYGEN, 0XYGEN, SPIRONOLACTONE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, DAPAGLIFLOZIN, ENOXAPARIN SODIUM, GABAPENTIN, ONDANSETRON HYDROCHLORIDE, |
||||
| 726 | 26441989 |
US |
33 | 1 |
Dry skin, Cough, Nasopharyngitis, Hypersensitivity, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 727 | 26442013 |
US |
1 | |
Muscle rupture, Fatigue, Nasopharyngitis, |
||||
RISANKIZUMAB-RZAA, |
||||
| 728 | 26442073 |
US |
61 | 2 |
Nasopharyngitis, Inappropriate schedule of product administration, |
||||
BARICITINIB, |
||||
| 729 | 26442089 |
US |
68 | 1 |
Nasopharyngitis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 730 | 26442758 |
US |
61 | 2 |
Nasopharyngitis, Cough, Respiratory tract congestion, |
||||
ABATACEPT, |
||||
| 731 | 26442948 |
CA |
43 | 2 |
Rheumatoid arthritis, Maternal exposure during pregnancy, Musculoskeletal pain, Stomatitis, Mobility decreased, Urticaria, Condition aggravated, Inflammation, Arthropathy, Confusional state, Muscle injury, Hand deformity, Helicobacter infection, Nasopharyngitis, Type 2 diabetes mellitus, Duodenal ulcer perforation, Breast cancer stage III, Hypoaesthesia, Osteoarthritis, Fibromyalgia, Pemphigus, Pericarditis, Systemic lupus erythematosus, Hypertension, Live birth, Facet joint syndrome, Swelling, Lip dry, Alopecia, Lower respiratory tract infection, C-reactive protein increased, Wheezing, Liver injury, Nail disorder, Fatigue, Psoriatic arthropathy, Obesity, Asthenia, Epilepsy, Bursitis, Wound infection, |
||||
ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ATOMOXETINE HYDROCHLORIDE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, LAMOTRIGINE, LAMOTRIGINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, SECUKINUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, SARILUMAB, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ERGOCALCIFEROL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, BUPRENORPHINE, BUPRENORPHINE, ERENUMAB-AOOE, ACETAMINOPHEN AND CODEINE, PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CANDESARTAN, CANDESARTAN, CANDESARTAN, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DEXPANTHENOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE, OXYCODONE, OXYCODONE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, |
||||
| 732 | 26443044 |
CA |
59 | 2 |
Nasopharyngitis, Vasculitis, Brain fog, |
||||
GABAPENTIN, ABATACEPT, |
||||
| 733 | 26443054 |
US |
||
Nasopharyngitis, |
||||
RISANKIZUMAB-RZAA, |
||||
| 734 | 26443074 |
CA |
68 | 2 |
Pneumonia, Peripheral swelling, Vertebral lateral recess stenosis, Sinusitis, Ligamentum flavum hypertrophy, Back pain, Cough, Spinal osteoarthritis, Oral candidiasis, Rhinalgia, Joint swelling, Drug ineffective, Nasal congestion, Spinal stenosis, Nasopharyngitis, Sinus pain, Arthralgia, Rhinorrhoea, Dysphonia, Pain in extremity, Osteoarthropathy, Paraesthesia, COVID-19, Sneezing, Inappropriate schedule of product administration, Knee arthroplasty, Toe operation, Ear pain, Circadian rhythm sleep disorder, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALUMINUM HYDROXIDE, SENNOSIDES, TOPIRAMATE, TOPIRAMATE SPINKLE, SODIUM FLUORIDE, SODIUM FLUORIDE F 18, SODIUM FLUORIDE F-18, TOOTHPASTE, SODIUM FLUORIDE F18, CLEAR MINT, GEL TOOTHPASTE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, METHOTREXATE, METHOTREXATE SODIUM, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, CANDESARTAN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, RIZATRIPTAN BENZOATE, ATORVASTATIN CALCIUM, EZETIMIBE, FLUCONAZOLE, SARILUMAB, SARILUMAB, SARILUMAB, LORATADINE, LORATADINE TABLET, STANDARDIZED SENNA CONCENTRATE, PREDNISONE, DIMENHYDRINATE, ERGOCALCIFEROL, PREGABALIN, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, STANNOUS FLUORIDE, CETYLPYRIDINIUM CHLORIDE, SODIUM FLUORIDE, POTASSIUM NITRATE, SODIUM FLUORIDE, INFLIXIMAB, VITAMIN C, DESOXIMETASONE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, CYCLOBENZAPRINE, ATENOLOL, |
||||
| 735 | 26443092 |
CA |
50 | 2 |
Immunodeficiency, Nasopharyngitis, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 736 | 26443147 |
GB |
||
Faecaloma, Product leakage, Influenza, Nasopharyngitis, Drug dose omission by device, Product dose omission issue, Product use issue, Product prescribing issue, Intentional dose omission, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 737 | 26443177 |
US |
2 | |
Metastasis, Transient ischaemic attack, Diarrhoea, Abdominal pain lower, Nasopharyngitis, Eating disorder, |
||||
OSIMERTINIB, |
||||
| 738 | 26443688 |
CA |
||
Exposure to SARS-CoV-2, Pharyngeal paraesthesia, Lacrimation increased, Pruritus, Abdominal pain upper, Fatigue, Asthma, Hypersensitivity, Nasal congestion, Infection, Cough, Nasopharyngitis, Sinusitis, Hypertension, Illness, Off label use, Incorrect dose administered, |
||||
RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, METHYLPREDNISOLONE SODIUM SUCCINATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METHYLPREDNISOLONE, IRBESARTAN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, |
||||
| 739 | 26443992 |
US |
60 | 2 |
Nasopharyngitis, |
||||
| 740 | 26444151 |
US |
66 | 1 |
Pneumonia, Adrenal insufficiency, Hernia, Decreased appetite, Nasopharyngitis, Headache, Blood pressure diastolic increased, Fatigue, Insomnia, Dyspnoea, Peripheral swelling, Rash, Dry skin, Confusional state, Heart rate increased, Diarrhoea, Contusion, Back pain, Asthenia, Thyroid hormones increased, Dysphonia, Dysuria, Tinnitus, Ageusia, Inflammation, Anxiety, Blood potassium decreased, Hypotension, Cardiac flutter, Nasopharyngitis, Nasal congestion, Dry mouth, Taste disorder, |
||||
LENVATINIB, LENVATINIB, LENVATINIB, BUMETANIDE, FINASTERIDE, ROSUVASTATIN CALCIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, LOSARTAN POTASSIUM, LOSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PEMBROLIZUMAB, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, EPLERENONE, |
||||
| 741 | 26444344 |
US |
2 | |
Nasopharyngitis, |
||||
DUPILUMAB, MONTELUKAST SODIUM, MONTELUKAST, EPINEPHRINE, MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PREDNISONE, CETIRIZINE HCL, CETIRIZINE, FAMOTIDINE, FLUOXETINE HYDROCHLORIDE, SAMBUCUS NIGRA FLOWERING TOP, SAMBUCUS NIGRA, BIOTIN, BLACK COHOSH, SENNOSIDES, SENNA LAXATIVE, SENNOSIDES 8.6 MG, PREDNISONE, |
||||
| 742 | 26444379 |
US |
2 | |
Fall, Tooth injury, Nasopharyngitis, Product use in unapproved indication, |
||||
SARILUMAB, SARILUMAB, |
||||
| 743 | 26444446 |
US |
61 | 1 |
Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 744 | 26444919 |
CA |
1 | |
Renal impairment, Osteoporosis, Nasopharyngitis, |
||||
PREDNISONE, TIOTROPIUM BROMIDE INHALATION SPRAY, ALBUTEROL SULFATE, |
||||
| 745 | 26444949 |
US |
56 | 1 |
Depressed mood, Ear discomfort, Tinnitus, Fatigue, Muscle spasms, Onychoclasis, Dry skin, Diarrhoea, Pallor, Madarosis, Myalgia, Therapeutic product effect incomplete, Feeling abnormal, Anxiety, Fear, Feeling jittery, Incorrect dose administered, Hypersensitivity, Alcohol intolerance, Nervousness, Visual impairment, Nasopharyngitis, Gastrointestinal disorder, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LEVOTHYROXINE SODIUM, |
||||
| 746 | 26445133 |
US |
37 | 2 |
Dystonia, Alanine aminotransferase increased, Weight decreased, Fatigue, Glucose tolerance impaired, Mood altered, Fall, Sleep disorder, Tardive dyskinesia, Foot fracture, Stress, Blood albumin increased, Agitation, Vitamin D decreased, Lower limb fracture, Restlessness, Anxiety, Parkinson^s disease, Somnolence, Gait disturbance, Tic, Tremor, Weight increased, Irritability, Low density lipoprotein increased, Sleep apnoea syndrome, Hypomania, Apathy, Huntington^s disease, Nasopharyngitis, Dyskinesia, Muscle twitching, Eating disorder, Akathisia, Depressed mood, Self-injurious ideation, Emotional poverty, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, LURASIDONE HYDROCHLORIDE, LURASIDONE HYDROCHLORIDE, LURASIDONE HYDROCHLORIDE, VALBENAZINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, LITHIUM, LITHIUM BROMATUM, LITHIUM, LITHIUM BROMATUM, ESZOPICLONE, PHENTERMINE HYDROCHLORIDE, FAMOTIDINE, BUPROPION HYDROCHLORIDE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, |
||||
| 747 | 26445189 |
US |
81 | 1 |
Nasopharyngitis, Cough, Nausea, Urinary tract infection, Vomiting, Renal disorder, Mobility decreased, |
||||
LENALIDOMIDE, |
||||
| 748 | 26445329 |
US |
60 | 1 |
Nasopharyngitis, |
||||
ABATACEPT, |
||||
| 749 | 26445482 |
US |
53 | 2 |
Nasopharyngitis, Productive cough, Tremor, Insomnia, Decreased appetite, Cough, Dizziness, Vision blurred, Lethargy, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, ALBUTEROL SULFATE, ALBUTEROL, METHYLPHENIDATE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, |
||||
| 750 | 26445488 |
JP |
27 | |
Ankylosing spondylitis, Nausea, Blepharospasm, Nasopharyngitis, Dizziness, Prescribed underdose, Off label use, Drug ineffective, |
||||
ROZANOLIXIZUMAB, ROZANOLIXIZUMAB, ROZANOLIXIZUMAB, ROZANOLIXIZUMAB, |
||||
| 751 | 26445523 |
CA |
19 | |
Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Autoimmune disorder, Blister, C-reactive protein, Condition aggravated, Confusional state, Contusion, Deep vein thrombosis postoperative, Discomfort, Nasopharyngitis, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Ill-defined disorder, Infection, Wound, Infusion related reaction, Injury, Joint swelling, Lip dry, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Malaise, Mobility decreased, Musculoskeletal stiffness, Night sweats, Oedema, Osteoarthritis, Pain, Pemphigus, Pericarditis, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Sciatica, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swollen joint count increased, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Weight increased, Drug intolerance, Therapy non-responder, Treatment failure, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALENDRONATE SODIUM, ALENDRONATE SODIUM, TRAMADOL HYDROCHLORIDE, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NEOMYCIN OINTMENT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREGABALIN, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, ACETAMINOPHEN AND CODEINE, LORAZEPAM, CAFFEINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PIROXICAM, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LISINOPRIL, MAGNESIUM, MELOXICAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RISEDRONATE SODIUM, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 752 | 26445573 |
CA |
1 | |
Nasopharyngitis, Influenza, |
||||
BENRALIZUMAB, BENRALIZUMAB, ERGOCALCIFEROL, CALCIUM, UMECLIDINIUM, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, |
||||
| 753 | 26445585 |
JP |
||
Immune-mediated myocarditis, Interstitial lung disease, Immune-mediated adrenal insufficiency, Haematochezia, Immune-mediated enterocolitis, Immune-mediated myasthenia gravis, Type 1 diabetes mellitus, Immune-mediated myositis, Gastrointestinal perforation, Immune-mediated hypothyroidism, Nasopharyngitis, Pyrexia, Dyspnoea, Malaise, Diarrhoea, Eyelid ptosis, Diplopia, |
||||
DURVALUMAB, |
||||
| 754 | 26445673 |
US |
34 | 1 |
Abdominal pain, Drug ineffective, Muscle spasms, Diarrhoea, Arthralgia, Laboratory test abnormal, Nasopharyngitis, Nasal congestion, Abdominal distension, Nausea, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RESMETIROM, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 755 | 26445795 |
|||
Nasopharyngitis, |
||||
LENIOLISIB, |
||||
| 756 | 26436340 |
US |
2 | |
Vertigo, Nasopharyngitis, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 757 | 26436359 |
CA |
40 | 2 |
Nasopharyngitis, Influenza, |
||||
TREPROSTINIL, TREPROSTINIL, |
||||
| 758 | 26436974 |
CA |
19 | |
Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Autoimmune disorder, Blister, C-reactive protein, Condition aggravated, Confusional state, Contusion, Deep vein thrombosis postoperative, Discomfort, Nasopharyngitis, Drug intolerance, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Ill-defined disorder, Infection, Wound, Infusion related reaction, Injury, Joint swelling, Lip dry, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Malaise, Mobility decreased, Musculoskeletal stiffness, Night sweats, Oedema, Osteoarthritis, Pain, Pemphigus, Pericarditis, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Sciatica, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swollen joint count increased, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Weight increased, Therapy non-responder, Treatment failure, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALENDRONATE SODIUM, ALENDRONATE SODIUM, TRAMADOL HYDROCHLORIDE, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NEOMYCIN OINTMENT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREGABALIN, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, ACETAMINOPHEN AND CODEINE, LORAZEPAM, CAFFEINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PIROXICAM, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LISINOPRIL, MAGNESIUM, MELOXICAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RISEDRONATE SODIUM, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 759 | 26437178 |
US |
56 | 2 |
Nasopharyngitis, |
||||
LENALIDOMIDE, |
||||
| 760 | 26437322 |
CA |
62 | 2 |
Haematochezia, Frequent bowel movements, Mucous stools, Influenza, Nasopharyngitis, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, MESALAMINE, NAPROXEN, NAPROXEN SODIUM, MESALAMINE, |
||||
| 761 | 26437377 |
CA |
14 | 2 |
Uveitis, Headache, Nasopharyngitis, Pyrexia, Vomiting, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 762 | 26437431 |
CA |
2 | |
Nasopharyngitis, Mobility decreased, Urinary tract infection, Confusional state, |
||||
NATALIZUMAB, |
||||
| 763 | 26437465 |
US |
||
Nasopharyngitis, |
||||
LENALIDOMIDE, MIDODRINE HYDROCHLORIDE, ROSUVASTATIN, GABAPENTIN, |
||||
| 764 | 26437485 |
US |
||
Nasopharyngitis, |
||||
BOSENTAN, |
||||
| 765 | 26437745 |
US |
50 | 2 |
Nasopharyngitis, Oropharyngeal pain, Dysphonia, |
||||
GALCANEZUMAB-GNLM, SUMATRIPTAN, |
||||
| 766 | 26437753 |
US |
74 | 1 |
Nasopharyngitis, |
||||
INSULIN LISPRO, |
||||
| 767 | 26437879 |
US |
63 | 2 |
Dizziness, Nasopharyngitis, |
||||
POMALIDOMIDE, |
||||
| 768 | 26438134 |
US |
71 | 2 |
Intercepted product storage error, Cough, Nasopharyngitis, |
||||
ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, |
||||
| 769 | 26438247 |
US |
21 | |
Nasopharyngitis, Illness, |
||||
ISOTRETINOIN, |
||||
| 770 | 26438273 |
US |
70 | |
Arthritis, Nasopharyngitis, Ageusia, Incorrect dose administered, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 771 | 26438594 |
US |
||
Nasopharyngitis, |
||||
MAVACAMTEN, |
||||
| 772 | 26438754 |
US |
2 | |
Illness, Ear infection, Crohn^s disease, Drug ineffective, Nasopharyngitis, Impaired work ability, Gait inability, Paradoxical psoriasis, Ear haemorrhage, Skin fissures, Drug specific antibody present, Rash, |
||||
ADALIMUMAB, ADALIMUMAB, ADALIMUMAB-ADAZ, |
||||
| 773 | 26438887 |
US |
2 | 1 |
Nasopharyngitis, |
||||
| 774 | 26439036 |
US |
58 | 1 |
Nasopharyngitis, Illness, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 775 | 26439177 |
US |
8 | 1 |
Asthma, Dyspnoea, Nasopharyngitis, Allergy to animal, |
||||
DUPILUMAB, |
||||
| 776 | 26439197 |
US |
53 | 2 |
Nasopharyngitis, Oropharyngeal pain, |
||||
DUPILUMAB, |
||||
| 777 | 26439200 |
US |
33 | 1 |
Anosmia, Nasopharyngitis, Pyrexia, Cough, Nasal congestion, Lack of injection site rotation, |
||||
DUPILUMAB, |
||||
| 778 | 26439234 |
US |
65 | 2 |
Sinusitis, Nasopharyngitis, Condition aggravated, |
||||
DUPILUMAB, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, ALBUTEROL SULFATE, ALPRAZOLAM, BIOTIN, BUDESONIDE, ALENDRONATE SODIUM, MINOXIDIL, CALCIUM, FISH OIL, MAGNESIUM, TRETINOIN, ERGOCALCIFEROL, |
||||
| 779 | 26439259 |
US |
2 | |
Nasopharyngitis, Chronic obstructive pulmonary disease, Injection site pain, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 780 | 26439298 |
US |
59 | 2 |
Malaise, Nasopharyngitis, |
||||
DUPILUMAB, OMALIZUMAB, |
||||
| 781 | 26439301 |
US |
1 | |
Injection site discolouration, Pruritus, Nasopharyngitis, Injection site pain, Rash, Eczema infantile, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 782 | 26439329 |
US |
2 | |
Cough, Respiratory syncytial virus infection, Nasopharyngitis, |
||||
DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 783 | 26439381 |
US |
14 | 1 |
Nasopharyngitis, |
||||
DUPILUMAB, ALBUTEROL SULFATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, EPINEPHRINE, ADRENALINUM, ITRACONAZOLE, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, |
||||
| 784 | 26439495 |
49 | ||
Psoriatic arthropathy, Nasopharyngitis, Skin plaque, Fatigue, Illness, Arthralgia, Skin disorder, Bedridden, Psoriasis, Drug ineffective, Therapeutic response shortened, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 785 | 26439644 |
IN |
67 | 1 |
Oedema peripheral, Nasopharyngitis, Pyrexia, Discharge, |
||||
DURVALUMAB, |
||||
| 786 | 26439822 |
CA |
48 | 1 |
Abdominal distension, Aggression, Arthralgia, Arthritis, Back pain, Depressive symptom, Gait inability, Hernia, Migraine, Movement disorder, Musculoskeletal stiffness, Nasopharyngitis, Pain, Pain in extremity, Pain of skin, Pyrexia, Respiratory tract infection, Stress, Urinary incontinence, Fatigue, Malaise, Gastritis, Asthma, Decreased appetite, Insomnia, Nausea, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, OMALIZUMAB, OMALIZUMAB, RANITIDINE HYDROCHLORIDE, CELECOXIB, ETANERCEPT, ADALIMUMAB, INDOMETHACIN, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, INFLIXIMAB, GOLIMUMAB, |
||||
| 787 | 26439922 |
US |
54 | 2 |
Gastrointestinal disorder, Fatigue, Weight increased, Nasopharyngitis, |
||||
AVAPRITINIB, |
||||
| 788 | 26440135 |
US |
2 | |
Neutrophil count decreased, Ascites, Neoplasm malignant, Tension, Chills, Pain in extremity, Hot flush, Myalgia, Pyrexia, Gastrointestinal disorder, Nasopharyngitis, |
||||
OLAPARIB, AMOXICILLIN, |
||||
| 789 | 26440137 |
US |
36 | 2 |
Nasopharyngitis, Chills, |
||||
LARONIDASE, |
||||
| 790 | 26440502 |
US |
2 | |
Nasopharyngitis, Rhinorrhoea, |
||||
DUPILUMAB, |
||||
| 791 | 26431042 |
US |
61 | 2 |
Immunodeficiency, Influenza, Nasopharyngitis, Dermatitis atopic, Pruritus, Skin lesion, Skin fissures, |
||||
DUPILUMAB, |
||||
| 792 | 26431128 |
EU |
50 | 2 |
Lower respiratory tract infection, Nasopharyngitis, |
||||
BENRALIZUMAB, BENRALIZUMAB, IPRATROPIUM BROMIDE, OMALIZUMAB, ALBUTEROL SULFATE, |
||||
| 793 | 26431197 |
US |
46 | 2 |
Nasopharyngitis, Condition aggravated, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 794 | 26431347 |
US |
2 | |
Pyrexia, Nasopharyngitis, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 795 | 26431359 |
US |
70 | 1 |
Malaise, Sinusitis, Nasopharyngitis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 796 | 26431368 |
US |
62 | 2 |
Sinus congestion, Nasopharyngitis, Secretion discharge, Productive cough, Facial pain, Dysphonia, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 797 | 26431482 |
US |
1 | |
Nasopharyngitis, Dysphonia, Skin fissures, Erythema, Dry skin, Pruritus, Rash, Skin discolouration, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 798 | 26431560 |
US |
46 | 1 |
Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 799 | 26431641 |
US |
58 | 2 |
Arthralgia, Muscle twitching, Nausea, Nasopharyngitis, Pruritus, |
||||
GALCANEZUMAB-GNLM, |
||||
| 800 | 26431847 |
US |
27 | 1 |
Seizure, Nasopharyngitis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28